Study unveils mechanisms behind antigenic variation in pathogens

A new study by LMU and Helmholtz Munich shows how pathogens control changes in their cell surface to evade the immune system.

Gilead, Cognizant expand deal to expedite digital transformation

The use of GenAI is intended to offer improved transparency about Gilead’s medicines to patients as well as internal staff. Credit: Sundry Photography / Shutterstock.com.

July 25, 2023

Multiple sclerosis has distinct subtypes, study finds, pointing to different treatments

For years, researchers have been hopeful they could get under the hood of multiple sclerosis. The neurological condition shows up in over 2.5 million people

March 27, 2024

Generative AI revolutionizes antibiotic development against resistant pathogens

With nearly 5 million deaths linked to antibiotic resistance globally every year, new ways to combat resistant bacterial strains are urgently needed.

March 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.